We have witnessed weight loss of 13–15% with the glucagon-like peptide-1 (GLP-1) receptor agonist semaglutide and up to 18–23% with the dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) ...

The Ozempic Effect has taken over, and it's having a huge impact on the plus size community and body positivity movement.

New GLP-1 weight-loss drugs are changing obesity treatment in India with promising health benefits. Dr. Ambrish Mithal, India ...

Given the controversial interplay between artificial sweeteners and weight loss, it’s not surprising that studies on their relationship abound. Unfortunately, the conclusions aren’t clear-cut.